Cancer or COVID-19? A Review of Recommendations for COVID-19 Vaccination in Cancer Patients
| Autor: | Manit K. Gundavda, Kaival K. Gundavda |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
medicine.medical_specialty
COVID-19 Vaccines COVID-19 vaccination medicine.medical_treatment Population Disease Medical Oncology Palliative and Supportive Care (MP Davis Section Editor) Safety and efficacy Medical oncology treatments Expert recommendations Patient safety Immunocompromised Host Prevention of SARS-CoV-2 infection Neoplasms medicine Humans Cancer care Pharmacology (medical) education Intensive care medicine Immunosuppression Therapy education.field_of_study business.industry SARS-CoV-2 Vaccination Cancer COVID-19 Immunosuppression medicine.disease Clinical trial Treatment Outcome Oncology Immunization Immune System Practice Guidelines as Topic Patient Safety business |
| Zdroj: | Current Treatment Options in Oncology |
| ISSN: | 1534-6277 |
| Popis: | Opinion statement While emergency use is authorized for numerous COVID-19 vaccines and the high-risk population including cancer patients or those with immunosuppression due to disease or therapy is prioritized, data on this group’s specific safety and efficacy of these vaccines remains limited. Safety data from clinical trials and population data may be extrapolated, and these vaccines may be used for cancer patients. However, concerns of efficacy due to the variable immune response in patients with active cancers undergoing active therapy and cancer survivors with chronic immunosuppression remain. The authors aim to discuss the current recommendations for use of COVID-19 vaccination in patients with cancer. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink